Melatonin protects the central nervous system of rats against toluene-containing thinner intoxication by reducing reactive gliosis

dc.contributor.authorBaydas, G
dc.contributor.authorReiter, RJ
dc.contributor.authorNedzvetskii, VS
dc.contributor.authorYasar, A
dc.contributor.authorTuzcu, M
dc.contributor.authorOzveren, F
dc.contributor.authorCanatan, H
dc.date.accessioned2026-08-12T17:26:20Z
dc.date.issued2003
dc.departmentFırat Üniversitesi
dc.description.abstractNeuroprotective effects of melatonin against free radical damage have been studied extensively. Thinner containing 60-70% toluene is a neurotoxic mixture which is widely used as an aromatic industrial solvent. This product has been shown to cause functional and structural changes in the central nervous system. Toluene generates reactive oxygen species (ROS) and the toxic effects relating to these reactants. In the present study we investigated glial reactivity in hippocampus, cortex and cerebellum and the expression of glial fibrillary acidic protein (GFAP) after exposure of rats to toluene vapor (3000 ppm) for 45 days. We also examined the protective effects of melatoriin against gliosis. Western blots demonstrated a marked elevation in total GFAP, a specific marker for astrocytes, by thinner fume inhalation in the hippocampus (P < 0.001), cortex (P < 0.01) and cerebellum (P < 0.05) of rats. Melatonin administration prevented the increase of total GFAP induced by thinner fume inhalation. Thinner exposure caused a significant increase of lipid peroxidation products (malondialdehyde and 4-hydroxyalkenals) in all brain regions (P < 0.01 for each region), and this elevation was also was inhibited by melatonin. Furthermore, melatonin augmented glutathione levels in all brain regions (P < 0.05 for each region) investigated. In conclusion, melatonin treatment may provide neuroprotection against toluene neurotoxicity by increasing the survival of glial cells possibly by directly scavenging ROS and by indirectly augmenting their antioxidant capacity. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
dc.identifier.doi10.1016/S0378-4274(02)00400-9
dc.identifier.endpage174
dc.identifier.issn0378-4274
dc.identifier.issn1879-3169
dc.identifier.issue3
dc.identifier.orcid0000-0001-7352-441X
dc.identifier.orcid0000-0002-1329-3143
dc.identifier.orcid0000-0002-1277-5976
dc.identifier.orcid0000-0002-9206-3177
dc.identifier.orcid0009-0003-4052-3367
dc.identifier.pmid12523959
dc.identifier.scopus2-s2.0-0037415377
dc.identifier.scopusqualityQ2
dc.identifier.startpage169
dc.identifier.urihttps://doi.org/10.1016/S0378-4274(02)00400-9
dc.identifier.urihttps://hdl.handle.net/11508/54767
dc.identifier.volume137
dc.identifier.wosWOS:000180833600005
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofToxicology Letters
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjecttoluene
dc.subjectglial fibrillary acidic protein
dc.subjectlipid peroxidation
dc.subjectmelatonin
dc.subjecthippocampus
dc.subjectcortex
dc.titleMelatonin protects the central nervous system of rats against toluene-containing thinner intoxication by reducing reactive gliosis
dc.typeArticle

Dosyalar